09 Feb 2022
Bionow Awards shortlisted nominees announced
Bionow, an award winning specialist business development and services company at the heart of the biomedical and life sciences sector in the North of England, has announced that the entries for the 2021 Bionow Awards have now been reviewed and the nominees have been finalised.
Showcasing the best of the life sciences sector, the prestigious Bionow Awards remains a highlight of the industry calendar. This year’s ceremony will take place in-person at the Concorde Conference Centre, Altrincham. A black tie ceremony will bring people together to celebrate excellence and provide attendees with an opportunity to mark the occasion in style.
This special event will recognise the outstanding success and achievements of those who have worked tirelessly over the last twelve months, and spotlight the incredible progress that has been made during a challenging period.
Health Innovation Manchester is joined by The Innovation Agency, Yorkshire & Humber AHSN and AHSN North East & North Cumbria in sponsoring the Bionow Product of the Year Award.
The Nominees Shortlist:
- FibroFind Ltd
- Pandeia Therapeutics Limited
- Sky Medical, Technology, Sky Medical Technology’s geko™ device improves care following kidney transplantation
- The Newcastle upon Tyne Hospitals NHS Foundation Trust, Delivering Advanced Therapies to NHS Patients at Scale
- University of Liverpool, Combined Intelligence for Population Health Action (CIPHA)
- LightOx, Apollo – Anti-fibrotic photodynamic therapy to relieve scleroderma
- QuantuMDx Group, Rapid deployment of the Q-POC SARS-CoV-2 cassette with Univac
- Reacta Biotech, Development of peanut allergy diagnostics
- South Tyneside and Sunderland NHS Foundation Trust, Shoulder Reduction Assistance Device
- Alderley Park Lighthouse Laboratory, Alderley Park Lighthouse Laboratory
- Aptamer Group, Optimer®-enabled Microtox®PD Wastewater Monitoring for COVID-19
- Origin Healthcare Services, Aseptic Filling Facility design build and production in 5 months
- University of Liverpool, Liverpool Covid-SMART Community Testing Pilot
- Balance App, Balance App Limited
- QuantuMDx Group, Q-POC™ SARS-CoV-2 assay
- Yourgene Health, LightBench® Powered by Ranger® Technology
- OLM Diagnostics Ltd, AurisID
- Aptamer Group, Optimer® platform to enable the life sciences
- ATMPS Ltd, Hataali blockchain based platform for ATMP supply chains
- Cresset Discovery, Cresset Discovery – Computational Solutions to Biological Problems
- Medicines Discovery Catapult, Medicines Discovery Catapult – Biomarker Discovery & Validation
- Chas Nelson, gliff.ai
- Hollie Leighton, Perfectus Biomed Group
- Molly Jowsey, QuantuMDx Group
- Ruth Watkinson, The University of Manchester
- CatSci Ltd
- Fibrofind Ltd
- Liverpool ChiroChem Limited
- Liverpool School of Tropical Medicine, The Swab and Send microbial library for antimicrobial discovery
- PhenUtest Diagnostics, Point-of-care urinary tract infection diagnostic to minimise antibiotic mis-prescribing
- Medicines Discovery Catapult, Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate
- BiVictriX Therapeutics, AIM-IPO of BiVictriX Therapeutics
- Aptamer Group, Aptamer Group IPO on AIM market
- Iksuda Therapeutics, $47m financing round to accelerate differentiated Antibody Drug Conjugate pipeline
To be announced on the evening.
To be announced on the evening.
Richard Deed, Associate Director – Industry at Health Innovation Manchester, said: “Health Innovation Manchester together with the three Northern AHSNs sees the Bionow awards as a way to stimulate and recognise the amazing work that health and life science companies develop and deliver, generating patient benefit and economic growth.
“It’s great to see a number of the shortlisted finalists including Yourgene, ATMPS, SkyMedical, Biovictrix and Balance have previously received support from Health Innovation Manchester. My best wishes go to all the nominees.”
Geoff Davison, CEO of Bionow, said: “We were blown away by the quality of the applications we received this year and are thrilled to have such a prestigious shortlist for our first in-person awards ceremony since the pandemic began.”
He added: “We can’t wait to see everyone again and celebrate the successes in what has continued to be a very demanding climate. This awards, which is also our 20th, promises to be the best yet and we hope to start 2022 as we mean to go on.”